Related Articles
Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer
Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer
Overexpression of ribosomal L1 domain containing 1 is associated with an aggressive phenotype and a poor prognosis in patients with prostate cancer
Overexpression levels of cripto‑1 predict poor prognosis in patients with prostate cancer following radical prostatectomy